Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy
NCT00424151
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
12
Enrollment
INDIV
Sponsor class
Conditions
Graves' Dysthyroid Ophthalmopathy
Thyroid Related Orbitopathy
Interventions
DRUG:
Rituximab
Sponsor
Silkiss, Rona Z., M.D., FACS
Collaborators
[object Object]
[object Object]
[object Object]